RU94045897A - Производные индола в качестве 5-hti-агонистов, фармацевтическая композиция и способ лечения - Google Patents

Производные индола в качестве 5-hti-агонистов, фармацевтическая композиция и способ лечения

Info

Publication number
RU94045897A
RU94045897A RU94045897/04A RU94045897A RU94045897A RU 94045897 A RU94045897 A RU 94045897A RU 94045897/04 A RU94045897/04 A RU 94045897/04A RU 94045897 A RU94045897 A RU 94045897A RU 94045897 A RU94045897 A RU 94045897A
Authority
RU
Russia
Prior art keywords
alkyl
rmeans
aryl
alkylaryl
compounds
Prior art date
Application number
RU94045897/04A
Other languages
English (en)
Other versions
RU2101283C1 (ru
Inventor
И.Мэйкор Джон
Us]
Дж.Уитс Мартин
Gb]
Original Assignee
Пфайзер Инк. (US)
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк. (US), Пфайзер Инк. filed Critical Пфайзер Инк. (US)
Publication of RU94045897A publication Critical patent/RU94045897A/ru
Application granted granted Critical
Publication of RU2101283C1 publication Critical patent/RU2101283C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Раскрываются соединения общей формулы, приведенной в описании, а также фармацевтически приемлемые соли этих соединений. Эти соединения являются новыми и могут быть использованы для лечeния мигрени и других расстройств. Указанные соединения являются ценными психотерапевтическими средствами и сильными агонистами серотонина (5-НТ) и могут быть использованы для лечения депрессии тревожных состояний, нарушений, связанных с приемом пищи, ожирения, злоупотребления наркотиками, "гистаминовой" головной боли, мигрени, болей хронической пароксизмальной гемикрании и головной боли, связанной с сосудистыми заболеваниями, а также для лечения других расстройств, связанных с недостаточной серотонинергической нейротрансмиссией. Кроме того, указанные соединения могут быть использованы в качестве гипотенсивных и сусудисторасширяющих средств центрального действия.

Claims (1)

  1. Раскрываются соединения общей формулы, приведенной в описании, а также фармацевтически приемлемые соли этих соединений. Эти соединения являются новыми и могут быть использованы для лечeния мигрени и других расстройств. Указанные соединения являются ценными психотерапевтическими средствами и сильными агонистами серотонина (5-НТ1) и могут быть использованы для лечения депрессии тревожных состояний, нарушений, связанных с приемом пищи, ожирения, злоупотребления наркотиками, "гистаминовой" головной боли, мигрени, болей хронической пароксизмальной гемикрании и головной боли, связанной с сосудистыми заболеваниями, а также для лечения других расстройств, связанных с недостаточной серотонинергической нейротрансмиссией. Кроме того, указанные соединения могут быть использованы в качестве гипотенсивных и сусудисторасширяющих средств центрального действия.
RU94045897/04A 1992-04-07 1993-03-10 Производные индола или их фармацевтически приемлемые соли RU2101283C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86473792A 1992-04-07 1992-04-07
US864,737 1992-04-07
PCT/US1993/001967 WO1993020073A1 (en) 1992-04-07 1993-03-10 Indole derivatives as 5-ht1 agonists

Publications (2)

Publication Number Publication Date
RU94045897A true RU94045897A (ru) 1996-09-10
RU2101283C1 RU2101283C1 (ru) 1998-01-10

Family

ID=25343950

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94045897/04A RU2101283C1 (ru) 1992-04-07 1993-03-10 Производные индола или их фармацевтически приемлемые соли

Country Status (26)

Country Link
US (7) US5747501A (ru)
EP (1) EP0635017A1 (ru)
JP (1) JP2644088B2 (ru)
KR (1) KR0179072B1 (ru)
CN (2) CN1050841C (ru)
AU (1) AU670579B2 (ru)
BR (1) BR9306201A (ru)
CA (1) CA2133413C (ru)
CZ (1) CZ281763B6 (ru)
EG (1) EG20226A (ru)
FI (1) FI931558A (ru)
HR (1) HRP930752A2 (ru)
HU (1) HUT64062A (ru)
IL (1) IL105206A (ru)
MX (1) MX9302011A (ru)
MY (1) MY108909A (ru)
NO (1) NO303388B1 (ru)
NZ (1) NZ251086A (ru)
PL (1) PL172405B1 (ru)
RU (1) RU2101283C1 (ru)
SK (1) SK280193B6 (ru)
TW (1) TW341565B (ru)
UA (1) UA27467C2 (ru)
WO (1) WO1993020073A1 (ru)
YU (1) YU48931B (ru)
ZA (1) ZA932440B (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
PL172405B1 (en) * 1992-04-07 1997-09-30 Pfizer Derivatives of indole
ES2070087B1 (es) * 1993-08-13 1996-02-16 Pfizer Derivados de indol
DK0716649T3 (da) * 1993-08-31 1999-02-08 Pfizer 5-Arylindolderivater
WO1995032196A1 (en) * 1994-05-19 1995-11-30 Merck Sharp & Dohme Limited Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
GB9415575D0 (en) * 1994-08-02 1994-09-21 Merck Sharp & Dohme Therapeutic agents
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
WO1996017842A1 (en) * 1994-12-06 1996-06-13 Merck Sharp & Dohme Limited Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists
CN1064682C (zh) * 1995-07-31 2001-04-18 盐野义制药株式会社 具有磷脂酶a2抑制活性的吡咯烷衍生物
GB9519558D0 (en) * 1995-09-26 1995-11-29 Merck Sharp & Dohme Therapeutic agents
US6051593A (en) * 1997-06-20 2000-04-18 Sugen, Inc. 3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors
EP1100501A4 (en) * 1998-06-30 2002-12-04 Lilly Co Eli PYRROLIDINE AND PYRROLIDINE DERIVATIVES INFLUENTING THE SYSTEMS ASSOCIATED WITH SEROTONIN
EP1103552A4 (en) * 1998-08-07 2003-01-15 Takeda Chemical Industries Ltd BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
US7041697B2 (en) * 2002-09-12 2006-05-09 Wyeth Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
JP5199121B2 (ja) * 2005-12-30 2013-05-15 メルク・シャープ・エンド・ドーム・コーポレイション Ｃｅｔｐ阻害剤
US8697689B2 (en) * 2008-10-16 2014-04-15 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
US20100217013A1 (en) * 2008-12-15 2010-08-26 Wenge Li Enantioselective process for the preparation of zolmitriptan
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
PT3447051T (pt) * 2016-04-28 2022-01-06 Jiangsu Hengrui Medicine Co Método para preparar um inibidor de tirosina quinase e um derivado do mesmo
KR20220137085A (ko) * 2020-02-04 2022-10-11 마인드셋 파마 인크. Cns 장애의 치료를 위한 세로토닌성 사이키델릭 작용제로서의 3-피롤리딘-인돌 유도체

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
US4689336A (en) * 1981-01-02 1987-08-25 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine 2,4-diones
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
FR2601008B1 (fr) * 1986-07-03 1990-03-30 Sanofi Sa Procede de synthese stereospecifique de derives de l'indole
US4968707A (en) * 1987-06-10 1990-11-06 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
WO1991018897A1 (en) * 1990-06-07 1991-12-12 The Wellcome Foundation Limited Therapeutic heterocyclic compounds
US5559129A (en) 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5607951A (en) 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5545644A (en) 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559246A (en) 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
HU225055B1 (en) * 1990-10-15 2006-05-29 Pfizer Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
TW263508B (ru) * 1991-02-12 1995-11-21 Pfizer
ES2143992T3 (es) 1991-11-25 2000-06-01 Pfizer Derivados de 5-(hetero- o carbociclilamino)-indol, su preparacion y uso como 5-ht1 agonistas.
CA2083891A1 (en) * 1991-12-03 1993-06-04 Angus Murray Macleod Heterocyclic compounds, compositions containing them and their use in therapy
US5409941A (en) 1992-02-03 1995-04-25 Pfizer Inc. 5-heteroyl indole derivatives
TW288010B (ru) 1992-03-05 1996-10-11 Pfizer
PL172405B1 (en) * 1992-04-07 1997-09-30 Pfizer Derivatives of indole
RU2110516C1 (ru) 1992-04-10 1998-05-10 Пфайзер Инк. Производные ациламиноиндола и производные аминоиндола

Also Published As

Publication number Publication date
KR950700906A (ko) 1995-02-20
FI931558A0 (fi) 1993-04-06
NO943762L (no) 1994-10-06
CA2133413C (en) 2001-04-10
AU670579B2 (en) 1996-07-25
ZA932440B (en) 1994-10-05
NZ251086A (en) 1996-09-25
SK120694A3 (en) 1995-05-10
US5747501A (en) 1998-05-05
HUT64062A (en) 1993-11-29
US6150388A (en) 2000-11-21
CN1083443C (zh) 2002-04-24
HRP930752A2 (en) 1994-10-31
SK280193B6 (sk) 1999-09-10
UA27467C2 (ru) 2000-09-15
IL105206A (en) 1999-04-11
YU23893A (sh) 1996-10-09
CZ246494A3 (en) 1995-06-14
EG20226A (en) 1997-12-31
AU3789893A (en) 1993-11-08
KR0179072B1 (ko) 1999-03-20
CN1225362A (zh) 1999-08-11
NO303388B1 (no) 1998-07-06
CA2133413A1 (en) 1993-10-14
US6465500B1 (en) 2002-10-15
JPH07504919A (ja) 1995-06-01
US6436957B1 (en) 2002-08-20
US6387937B1 (en) 2002-05-14
US6410739B1 (en) 2002-06-25
CN1050841C (zh) 2000-03-29
WO1993020073A1 (en) 1993-10-14
FI931558A (fi) 1993-10-08
TW341565B (en) 1998-10-01
JP2644088B2 (ja) 1997-08-25
BR9306201A (pt) 1998-06-23
MX9302011A (es) 1994-03-31
CN1082543A (zh) 1994-02-23
MY108909A (en) 1996-11-30
HU9301003D0 (en) 1993-06-28
EP0635017A1 (en) 1995-01-25
IL105206A0 (en) 1993-07-08
NO943762D0 (no) 1994-10-06
CZ281763B6 (cs) 1997-01-15
YU48931B (sh) 2002-12-10
US6387941B1 (en) 2002-05-14
PL172405B1 (en) 1997-09-30
RU2101283C1 (ru) 1998-01-10

Similar Documents

Publication Publication Date Title
RU94045897A (ru) Производные индола в качестве 5-hti-агонистов, фармацевтическая композиция и способ лечения
JP5246779B2 (ja) 新規クルクミン誘導体
RU2095360C1 (ru) Производные индола, их оптические изомеры и фармацевтически приемлемые соли
US5468768A (en) Antimigraine derivatives of indolylcycloalkanylamines
RU95109927A (ru) Производные 5-арилиндола и их применение в качестве агонистов серотонина (5-ht*00i)
US4059621A (en) Substituted benzamido propanolamines
RU94040914A (ru) Производные индола как вещества, обладающие сродством к рецептору 5-нтi, фармкомпозиция и способ лечения
KR970705557A (ko) 편두통 치료제인 인돌 유도체의 염(salts of an anti-migraine indole derivative)
RU94045902A (ru) Производные ациламиноиндола в качестве 5-hti агонистов, фармацевтическая композиция и способ лечения
US20040023970A1 (en) 1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
FR2567885A1 (fr) Derives 3-aminopropoxyaryliques, leur preparation, leur application comme medicaments et compositions pharmaceutiques les contenant
US7671079B2 (en) Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
JP2006518385A (ja) ５−ヒドロキシトリプタミン−６リガンドとしてのヘテロサイクリル−３−スルホニルインダゾール
NO174052C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive indolderivater
IL176111A (en) Derivatives 2– (H1– indulisulphenyl) –benzyl amine as SSRI
HUP0002830A2 (hu) Indol- és 2,3-dihidroindol-származékok, előállításuk és gyógyászati alkalmazásuk
RU94043324A (ru) Гетеробициклические соединения
EP0445781B1 (en) 3-Arylcarbonyl-1-aminoalkyl-1H-indole containing antiglaucoma compositions
KR900007419A (ko) 1-[모노-또는 비스(트리플루오로메틸)-2-피리디닐]피페라진을 함유한 약학조성물
JPH06511261A (ja) 新規なインドール誘導体
KR960702442A (ko) 타이로신 키나아제 억제인자로서의 치환된 β-아릴 및 β-헤테로아릴-α-시아노아크릴아미드 유도체(Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors)
US5618816A (en) Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
WO2007053353A2 (en) Pyrrolo[2,3-f] and [3,2-f]isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands
HU912901D0 (en) Method for producing 3-(1h-indazole-3-yl)-4-pyridine amines and pharmaceutical preparatives containing said compounds
JPS61158971A (ja) ２‐（アリルアルキルオキシメチル）モルフオリン誘導体、その製造方法およびそれを成分とする薬剤

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20040311